期刊文献+

猪C3d分子佐剂PRRSV GP5基因核酸疫苗的构建及免疫效果的研究 被引量:2

Construction and Immunogenicity of DNA Vaccines Containing GP5 Gene Against PRRSV with Porcine C3d as Molecular Adjuvant
下载PDF
导出
摘要 【目的】构建猪繁殖与呼吸综合征病毒(PRRSV)GP5基因C3d-P28分子佐剂重组质粒,探明C3d-P28分子佐剂的免疫增强效果。【方法】用大肠杆菌疫苗对健康猪进行免疫激活,提取猪肝脏总RNA,RT-PCR克隆C3d-P28并连接至pUC19载体,构建pUC19-P28.n(2、4、6)串联体,然后分别将P28.n(2、4、6)连接至真核表达载体pcDNA3.1构建成pcDNA3.1-P28.n(2、4、6)。RT-PCR扩增PRRSV GP5基因,分别定向克隆至pcDNA3.1-P28.n(2、4、6)中,构建pcDNA3.1-GP5-P28.n(2、4、6)重组质粒;提取重组质粒进行双酶切、电泳,同时用重组质粒转染Marc 145细胞,经间接免疫荧光进行蛋白表达检测,并用重组质粒免疫小鼠,通过ELISA试剂盒检测小鼠体内抗体、IL-4和IFN-γ的水平,检验重组质粒的免疫效果。【结果】从猪肝脏中克隆了C3d cDNA,构建了pcDNA3.1-P28.n(2、4、6)串联体,并将PRRSV GP5基因定向克隆至真核表达载体pcDNA3.1-P28.n(2、4、6)中,构建了PRRSV GP5重组质粒(pcDNA3.1-GP5-P28.2、pcDNA3.1-GP5-P28.4、pcDNA3.1-GP5-P28.6);通过检测小鼠血清中抗体、IL-4和IFN-γ的结果显示,抗体效价、IL-4和IFN-γ含量均比对照组高,且以pcDNA3.1-GP5-P28.6组的效果最好,与空白对照及PCDNA3.1-GP5组比较差异均显著(P<0.05)。【结论】构建了猪补体C3d-P28分子佐剂PRRSV GP5重组质粒,该质粒可刺激机体产生较高的体液免疫和细胞免疫水平,补体C3d-P28分子佐剂能显著增强PRRSV GP5基因的免疫效果。 【 Objective】DNA vaccines containing PRRSV GP5 gene with porcine C3d-p28 were constructed and the enhancing effect of molecular adjuvant C3d-p28 was proved.【Method】Pigs were injected with the oil emulsion of Escherichia coli inactivated vaccine in order to induce immune activation.After cloning the C3d cDNA of pig by using liver as the source of mRNA,a pair of primers was designed to sub clone the P28 gene to the pUC19 plasmid.Several tandems of p28 were constructed in the pUC19 plasmid using a pair of isoschizomers BamHI and Bgl II.The genes of p28.n,which were digested from pUC19-p28.n,were cloned into pcDNA3.1(+) plasmid.The GP5 gene of PRRSV was cloned by RT-PCR and inserted into the upstream of pcDNA3.1-p28.n plasmid,and the DNA vaccines containing GP5 gene with C3d-p28 as molecular adjuvant were successfully constructed.All recombinant plasmids were verified by PCR,restriction endonuclease digestion and DNA sequencing.In addition,indirect immunofluorescence assay(IFA) could be found within the cells after Mark145 cells tranfected by recombinant plasmids.Furthermore,seven groups of mice were injected with these recombinant plasmids.GP5-specific ELISA antibody,IFN-γlevel and IL-4 level in the sera were detected.【Result】It was showed that the C3d cDNA of pig was cloned and several tandems of P28 and pcDNA3.1(+)-GP5-C3d-p28.n were successfully constructed.Serological analysis showed that BALB/c mice that vaccinated with DNA vaccine expressing fusions of pcDNA3.1-GP5-p28(two,four or six repeats) elicited a higher level of humoral response compared with mice that vaccinated with DNA vaccine expressing only the pcDNA3.1 vector and pcDNA3.1-GP5 group(P 0.05).The increase in the immune response elicited by six copies of p28 was the highest.【Conclusion】The DNA vaccine containing PRRSV GP5 gene with porcine C3d-p28 has been successfully constructed,which could elicit humoral and cellular immune responses.The complement C3d–p28 can significantly enhance the nucleic acid vaccine immune effect as molecular adjuvant.
出处 《中国农业科学》 CAS CSCD 北大核心 2011年第12期2582-2588,共7页 Scientia Agricultura Sinica
基金 山东省自然科学基金(Y2007D47)
关键词 PRRSV C3d-p28佐剂 GP5基因疫苗 免疫效果 PRRSV C3d-p28 molecular adjuvant GP5 DNA vaccine effect of immunity
  • 相关文献

参考文献26

  • 1Dempsy P W, Allison M E, Akkaraju S. C3d of complement as molecular adjuvant ,bridging innate and acquired immunity. Science, 1996, 271: 348-350.
  • 2Green T D, Newton B R, Rota P A, Xu Y, Robinson H L, Ross T M. C3d enhancement of neutralizing antibodies to measle hemagglutinin. Vaccine, 2002, 20: 242-248.
  • 3Movsesyan N, Mkrtichyan M, Petrushina I, Ross T M, Cribbs D H, Agadjanyan M G, Ghochikyan A. DNA epitope vaccine containing complement component C3d enhances anti-amyloid-β antibody production and polarizes the immune response towards a Th2 phenotype. Journal of Neuroimmunology, 2008, 205: 57-63.
  • 4Gor D O, Ding X D, Li Q, Greenspan N S. Genetic fusion of three tandem copies of murine C3d sequences to diphtheria toxin fragment B elicits a decreased fragment B-specificantibody response. Immunology Letters, 2006, 102 : 38-49.
  • 5Suradhat S, Braun R P, Lewis P J, Babiuk L A, van Drunen S, den Hurk L, Griebel P J, Baea-Estrada M E. Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization. Veterinary Immunology and lmmunopathology, 2001, 83: 79-92.
  • 6Bergmann-Leitner E S, Duncan E H, Leitner W W, Neutzner A, Savranskaya T, Angov E, Tsokos G C. C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei. Vaccine, 2007, 25: 7732-7736.
  • 7Wang L S, Sunyer J O, Bello L J. Immunogenicity of a bovine viral diarrhea virus E2-C3d fusion protein containing a bovine homolog of C3d. Developmental and Comparative Immunology, 2005, 29: 907-915.
  • 8Mitchell J A, Green T D, Bright R A, Ross T M. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine, 2003, 21(9-10): 902-914.
  • 9Green T D, Newton B R, Rota P A, Xu Y, Robinson H L, Ross T M C3d enhancement of neutralizing antibodies to measles hemagglutinin Vaccine, 2001,20 (1-2): 242-248.
  • 10Larsen D L, Karasin A, Olsen C W. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting. Vaccine, 2001, 19 (20-22): 2842-2853.

二级参考文献100

共引文献48

同被引文献19

  • 1聂青和,罗新栋,张亚飞,黄晓峰,李军,邵彬,程勇前,陈朝霞.HCV感染人滋养层细胞过程中抗体依赖性增强作用的初步研究[J].胃肠病学和肝病学杂志,2006,15(4):379-382. 被引量:3
  • 2Hawkes RA. 1964. Enhancement of infecticity of arboviruses by spe- cific antisera produced in domestic fowls. Australian Journal of Ex- perimental Biology and Medical Science,42 ( 8 ) :465 -482.
  • 3Halstead SB,O'Rourke EJ, Allison AC. 1977. Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitn9 infection. Joum'M of Experimental Medicine, 146 ( 1 ) :218 -229.
  • 4Pcifis JS, Gordon S, Unkeless JC, et al. 1981. Monoc]onal anti - Fc receptor IgC blocks antibody enhancement of viral replication in mac- rophages. Nature,289(5794) :189 - 191.
  • 5Cardosa MJ, Porterfield JS, Gordon S. 1983. Complement receptor mediates enhanced flavivirus replication in macrophages. Journal Of Experimental Medicine,158 ( 1 ) :258 -263.
  • 6Fust G. 1997. Enhancing antibodies in HIV infection. Parasitology, 115 Suppl : S127 - 140.
  • 7Sullivan N,Sun Y, Binley J,et al. 1998. Determinants of human im- munodeficiency virus type 1 envelope glycoprotein activation by solu- ble CIM and monoclonal antibodies. Journal of Virology, 72 ( 8 ) : 6332 -6338.
  • 8Halstead SB. 1980. Dengue haemorrhagic fever - a public health problem and a field for research. Bulletin of the World Health Or- ganization ,58( 1 ) : 1 -21.
  • 9Halstead SB,Shot'well H, Casals J. 1973. Studies on the pathogene- sis of dengue infection in monkeys. 11. Clinical laboratory responses to heterologons infection. Jonrnal of Infectious Diseases, 128 ( 1 ) : 15 -22.
  • 10Morens DM. 1994. Antibody - dependent enhancement of infection and the pathngenesis of viral dioease. Clinical Infectious Diseases, 19(3) :500 -512.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部